Cargando…
EML4-ALK融合基因在非小细胞肺癌中的临床意义
Lung cancer continues to be the leading cause of cancer death worldwide, and non-small cell lung cancer (NSCLC) is the most common type of lung cancer. Molecular targeted therapy is the most promising development part in the treatment of NSCLC. In recent years, more and more attention has been focus...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
中国肺癌杂志编辑部
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6000390/ https://www.ncbi.nlm.nih.gov/pubmed/23425902 http://dx.doi.org/10.3779/j.issn.1009-3419.2013.02.07 |